A carregar...
Cereblon and IRF4 Variants Affect Risk and Response to Treatment in Multiple Myeloma
Multiple myeloma (MM) is a plasma-cell malignancy derived from an early precursor of the B-cell lineage characterised by bone-marrow infiltration, lytic bone lesions, and the presence of a monoclonal protein in serum and/or urine. Interferon regulatory factor 4 (IRF4) is a critical transcriptional r...
Na minha lista:
| Publicado no: | Arch Immunol Ther Exp (Warsz) |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Springer International Publishing
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5334380/ https://ncbi.nlm.nih.gov/pubmed/28083618 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00005-016-0442-6 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|